patients with hepatic disorders in which liver blood flow is altered , such as cirrhosis , have profound changes in pharmacokinetics with both short- and long-term administration of verapamil and are likely to have similar changes with other calcium antagonists .
C0023895
hepatic disorders
C0023890
cirrhosis